Do low total short-chain fatty acids reflect reduced fermentation and link to IBS symptoms?

Short-chain fatty acids (SCFAs), primarily acetate, propionate, and butyrate, serve as the primary metabolic markers of microbial fermentation in the colon. These metabolites function as critical signaling molecules that bridge the gap between the gut microbiome and host physiology. Evidence consistently shows that low SCFA concentrations are markers of dysbiosis and are directly implicated in the pathogenesis of gastrointestinal dysfunction and systemic immune dysregulation.

Clinical evidence and IBS association

Low fecal SCFA levels, particularly butyrate, are strongly associated with increased symptom severity in Irritable Bowel Syndrome (IBS).

• In constipation-predominant IBS (IBS-C), reduced SCFA concentrations correlate with slower colonic transit times and higher scores on the IBS Symptom Severity Scale (IBS-SSS).
• Interventions that increase fecal SCFAs, such as specific prebiotic fibers or probiotics, have demonstrated the ability to reduce visceral hypersensitivity and improve overall bowel habits.

Mechanistic explanations

SCFAs modulate gut health through both receptor-mediated signaling and epigenetic regulation:

• Colonic Motility: SCFAs act as ligands for G-protein-coupled receptors GPR41 (FFAR3) and GPR43 (FFAR2) on enteroendocrine cells. This activation triggers the release of serotonin (5-HT) and glucagon-like peptide-1 (GLP-1), which are essential for driving peristaltic contractions.
• Immune Signaling: SCFAs maintain immune homeostasis by inhibiting histone deacetylases (HDACs) and activating GPR109A. This promotes the differentiation of regulatory T cells (Tregs) via the Foxp3 locus, suppressing pro-inflammatory cytokines like TNF-α and IL-6.
• Barrier Integrity: Butyrate is the primary energy source for colonocytes and upregulates tight junction proteins such as occludin and ZO-1, preventing the "leaky gut" associated with visceral pain.

Considerations for interpretation

While total fecal SCFAs reflect fermentation output, they represent a net value of production minus absorption. A critical confounder is colonic transit time (CTT); slower transit allows for more extensive absorption by the colonic mucosa, which can lead to low fecal readings even if production is moderate. Conversely, rapid transit may lead to higher fecal levels due to limited absorption time.

Bottom line

Low total SCFAs indicate reduced fermentation output or altered absorption and are scientifically linked to impaired motility, pro-inflammatory immune signaling, and increased IBS symptom severity. For a 70-year-old female, maintaining SCFA production is vital for preserving intestinal barrier integrity and regulating colonic transit.